H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Price:
21.95
HKD
1.15%
Market Closed
Market Cap:
130.3B
HKD
Balance Sheet
Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group Company Ltd
| Current Assets | 27.4B |
| Cash & Short-Term Investments | 23.4B |
| Receivables | 3.2B |
| Other Current Assets | 885.8m |
| Non-Current Assets | 4.2B |
| Long-Term Investments | 702.3m |
| PP&E | 3.3B |
| Intangibles | 245.3m |
Balance Sheet
Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group Company Ltd
Currency: CNY
Millions
Annual
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
197
|
257
|
653
|
8 238
|
4 285
|
14 702
|
17 615
|
22 435
|
22 622
|
|
| Cash |
0
|
0
|
0
|
0
|
4 285
|
14 702
|
17 615
|
22 435
|
22 622
|
|
| Cash Equivalents |
197
|
257
|
653
|
8 238
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
1 147
|
1 467
|
2 840
|
6 355
|
9 433
|
4 231
|
4 008
|
2 422
|
765
|
|
| Total Receivables |
1 740
|
2 213
|
2 674
|
2 279
|
3 210
|
3 782
|
3 674
|
3 321
|
3 170
|
|
| Accounts Receivables |
1 572
|
1 372
|
1 605
|
1 551
|
2 744
|
3 247
|
3 534
|
3 210
|
3 170
|
|
| Other Receivables |
167
|
842
|
1 069
|
728
|
467
|
535
|
140
|
111
|
0
|
|
| Inventory |
353
|
439
|
480
|
414
|
299
|
410
|
448
|
576
|
651
|
|
| Other Current Assets |
27
|
42
|
38
|
161
|
59
|
54
|
86
|
130
|
235
|
|
| Total Current Assets |
3 464
|
4 418
|
6 684
|
17 448
|
17 286
|
23 179
|
25 832
|
28 883
|
27 442
|
|
| PP&E Net |
1 231
|
1 329
|
1 581
|
2 123
|
3 468
|
3 569
|
3 483
|
3 294
|
3 268
|
|
| PP&E Gross |
1 231
|
1 329
|
1 581
|
2 123
|
3 468
|
3 569
|
3 483
|
3 294
|
0
|
|
| Accumulated Depreciation |
536
|
655
|
773
|
925
|
1 128
|
1 360
|
1 645
|
1 963
|
0
|
|
| Intangible Assets |
6
|
9
|
10
|
5
|
10
|
17
|
33
|
177
|
245
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
28
|
395
|
654
|
685
|
702
|
|
| Other Long-Term Assets |
120
|
118
|
139
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4 821
N/A
|
5 874
+22%
|
8 414
+43%
|
19 575
+133%
|
20 792
+6%
|
27 160
+31%
|
30 002
+10%
|
33 039
+10%
|
31 658
-4%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
45
|
99
|
159
|
193
|
124
|
248
|
222
|
164
|
218
|
|
| Accrued Liabilities |
752
|
849
|
1 028
|
1 459
|
1 877
|
2 201
|
1 925
|
1 969
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
4
|
11
|
10
|
16
|
4 199
|
57
|
|
| Other Current Liabilities |
1 015
|
280
|
3 317
|
4 585
|
677
|
565
|
457
|
530
|
2 420
|
|
| Total Current Liabilities |
1 812
|
1 228
|
4 504
|
6 240
|
2 690
|
3 024
|
2 620
|
6 863
|
2 695
|
|
| Long-Term Debt |
0
|
0
|
0
|
6
|
82
|
3 818
|
4 362
|
104
|
61
|
|
| Deferred Income Tax |
35
|
128
|
243
|
285
|
122
|
267
|
351
|
255
|
200
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1 200
|
0
|
23
|
23
|
22
|
22
|
22
|
|
| Total Liabilities |
1 847
N/A
|
1 355
-27%
|
5 946
+339%
|
6 531
+10%
|
2 916
-55%
|
7 131
+145%
|
7 355
+3%
|
7 244
-2%
|
2 978
-59%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1 597
|
3 192
|
1 095
|
1 952
|
4 589
|
6 987
|
9 034
|
11 671
|
28 693
|
|
| Additional Paid In Capital |
1 302
|
1 302
|
1 302
|
10 837
|
14 009
|
14 024
|
13 932
|
14 096
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
58
|
28
|
109
|
13
|
|
| Other Equity |
75
|
24
|
70
|
256
|
722
|
924
|
291
|
137
|
0
|
|
| Total Equity |
2 974
N/A
|
4 519
+52%
|
2 468
-45%
|
13 044
+429%
|
17 876
+37%
|
20 029
+12%
|
22 647
+13%
|
25 795
+14%
|
28 680
+11%
|
|
| Total Liabilities & Equity |
4 821
N/A
|
5 874
+22%
|
8 414
+43%
|
19 575
+133%
|
20 792
+6%
|
27 160
+31%
|
30 002
+10%
|
33 039
+10%
|
31 658
-4%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
5 161
|
5 161
|
5 161
|
5 789
|
5 919
|
5 918
|
5 920
|
5 924
|
5 934
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
